v3.26.1
BASIS OF FINANCIAL STATEMENT PREPARATION (Details)
$ in Millions
3 Months Ended 12 Months Ended
Mar. 31, 2026
country
segment
Sep. 30, 2025
USD ($)
Mar. 31, 2025
USD ($)
Dec. 31, 2025
Mar. 09, 2024
USD ($)
Concentration Risk [Line Items]          
Number of countries with primary office locations | country 5        
Number of operating segments | segment 1        
Number of reportable segments | segment 1        
Customer one | Accounts receivable and unbilled services | Customer concentration risk          
Concentration Risk [Line Items]          
Concentration risk, percentage 18.50%        
Customer one | Revenue | Customer concentration risk          
Concentration Risk [Line Items]          
Concentration risk, percentage 17.20%   15.40%    
Pharmaceutical company one | Accounts receivable and unbilled services | Customer concentration risk          
Concentration Risk [Line Items]          
Concentration risk, percentage       18.30%  
Discontinued operations, disposed of by sale | Enabling Services segment disposal          
Concentration Risk [Line Items]          
Discontinued operations, consideration         $ 340.0
Discontinued operations, consideration, cash         295.0
Discontinued operations, consideration, liability         $ 45.0
Milestone payment   $ 25.0 $ 20.0